These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2714362)

  • 1. Response by the neurotensin systems of the basal ganglia to cocaine treatment.
    Hanson GR; Smiley P; Johnson M; Letter A; Bush L; Gibb JW
    Eur J Pharmacol; 1989 Jan; 160(1):23-30. PubMed ID: 2714362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
    Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
    J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
    Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
    Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the limbic neurotensin systems induced by dopaminergic drugs.
    Merchant KM; Letter AA; Gibb JW; Hanson GR
    Eur J Pharmacol; 1988 Aug; 153(1):1-9. PubMed ID: 2905662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment.
    Hanson GR; Midgley LP; Bush LG; Gibb JW
    Eur J Pharmacol; 1995 May; 278(2):167-73. PubMed ID: 7672001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems.
    Johnson M; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1991 Feb; 193(3):367-70. PubMed ID: 1675997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
    Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
    Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments.
    Alburges ME; Ramos BP; Bush L; Hanson GR
    Eur J Pharmacol; 2000 Feb; 390(1-2):119-26. PubMed ID: 10708715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mephedrone alters basal ganglia and limbic neurotensin systems.
    German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
    J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
    Hanson GR; Singh N; Bush L; Gibb JW
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
    Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
    Letter AA; Merchant K; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
    Masuda T; Fujimoto H; Kawai H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):362-74. PubMed ID: 2842204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.